Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Prof. Pavel Jansa was educated at the Charles University in Prague, First Faculty of Medicine (1996). He specialised in internal medicine in 1999 and cardiology in 2005. He is Chief of the Centre for Pulmonary Hypertension at the Department of Cardiology and Angiology, General University Hospital in Prague, and Professor at the First Faculty of Medicine, Charles University, Prague. Dr. Jansa is chairman of the Working Group on Pulmonary Circulation of the Czech Society of Cardiology. His research interests include epidemiology of pulmonary hypertension, coagulation disorders in pulmonary hypertension, small-vessel disease in chronic thromboembolic pulmonary hypertension, and balloon pulmonary angioplasty. He has served as the principal investigator and steering committee member of pulmonary hypertension clinical trials. Dr. Jansa has co-authored research articles published in the New England Journal of Medicine, Lancet, European Heart Journal, European Respiratory Journal, Circulation, Journal of the American College of Cardiology, Chest, Pulmonary Circulation and numerous other peer-reviewed medical journals.
Marcin Kurzyna is the Head of Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology of Centre of Postgraduate Medical Education in Warsaw. He is a specialist in internal medicine and cardiology and has a PhD in respiratory medicine. His research interests are related to role of invasive procedures in diagnosis and treatment of pulmonary vascular diseases.
Professor of Vascular Biology, Medical University of Vienna. Professor Irene Marthe Lang is a senior staff member at the Department of Cardiology, and deputy Chairwoman of the Department. Irene M. Lang, carried out her medical education and residency at the University of Vienna, before taking on a 5-year postdoctoral research fellowship at the University of California, which included a joint appointment with the Scripps Research Institute. Since 2004, she has been Professor of Vascular Biology at the Medical University of Vienna. Professor Lang is leading a clinical and experimental group in vascular medicine, with one focus on pulmonary vascular biology and right ventricular function. Professor Lang has been leading numerous studies in the cardiovascular field, including a trial on myocardial regeneration employing intramyocardial cell injections.
Dr Lang is an active interventional and structural cardiologist with a case load of >15,000, and an active researcher with >800 impact points and an h-Factor of 30. She was nominated by the World Medical Association as a “Caring Physician of the World” in 2006, Teacher of the Year at the Medical University of Vienna in 2013, and is past president of the Austrian Society of Cardiology. Dr Lang is part of the International CTEPH Association (ICA), with the objectives to increase awareness for CTEPH, foster worldwide collaboration among CTEPH centers, serve as platform for surgical centers, facilitate training of emerging CTEPH centers, and advance research and education in CTEPH. Dr Lang is directing an outpatient unit for pulmonary vascular disease at the Medical University of Vienna.
Graduated from the Medical University of Warsaw in 1978. Specialized in cardiology ad angiology. Former head of the Department of Pulmonary Circulation and Thromboembolic Diseases, Medical Center for Postgraduate Education, ECZ- Otwock.
Coordinator of ESC Guidelines for Diagnosis and Treatment of Pulmonary Embolism (2000, 2008, 2014), co-author of ESC/ERS guidelines on diagnosis and treatment of pulmonary hypertension (2004, 2009, 2015). Chairman of the Working Group on Pulmonary Circulation and Right Ventricular Function of the ESC (2004-2006). In the years 2004-2007 he presided over the Polish Cardiac Society and between 2010 and 2012 served as Vice-President of the European Society of Cardiology.
Main research interests: pulmonary circulation (acute pulmonary embolism, chronic thromboembolic pulmonary hypertension, pulmonary arterial hypertension), right ventricular function, thromboembolic diseases, cardiovascular imaging and cardiovascular biomarkers